𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis

✍ Scribed by Alexandra Balbir-Gurman; Yolanda Braun-Moscovici; Vladimir Livshitz; Daniel Schapira; Doron Markovits; Alexander Rozin; Tatiana Boikaner; A. Menahem Nahir

Book ID
106264922
Publisher
Springer
Year
2007
Tongue
English
Weight
111 KB
Volume
26
Category
Article
ISSN
0770-3198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral iloprost treatment in patients with
Oral iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis: A multicenter, placebo-controlled, double-blind study
✍ Fredrick M. Wigley; Joseph H. Korn; M. E. Csuka; Thomas A. Medsger Jr.; Naomi F. 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 876 KB

## Objective: To evaluate the efficacy and tolerability of an oral preparation of iloprost, a prostacyclin analog, in patients with raynaud's phenomenon (rp) secondary to systemic sclerosis (scleroderma). ## Methods: A multicenter, randomized, parallel-group, placebo-controlled double-blind study